...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Differences of Opinion
5
May 24, 2016 10:55AM

I expect an RTO/IPO when they can pair it with positive news -- probably Phase I results. Without that, I think we'll get the "massive liquidation event" that fouremm mentioned. They are not going to to a public listing if the stock is likely to get pounded.

4
May 24, 2016 01:42PM

May 24, 2016 02:55PM
8
May 24, 2016 04:25PM
2
May 24, 2016 06:59PM
1
May 24, 2016 10:59PM
4
May 24, 2016 11:43PM
1
May 24, 2016 11:48PM
Share
New Message
Please login to post a reply